Healthcare -
Biotechnology - NASDAQ - US
$ 6.29
-4.26 %
$ 312 M
Market Cap
-1.26
P/E
RGNX - NET INCOME
Net Income RGNX - REGENXBIO Inc.
-263 M
LAST VALUE
-74.96%
2 YEAR CAGR
-29.46%
5 YEAR CAGR
-47.55%
10 YEAR CAGR